Overview

* Seer Q3 2025 revenue rose 2% yr/yr to $4.1 mln, driven by product and service sales

* Net loss for Q3 2025 was $18.2 mln, an improvement from $21.3 mln last year

* Company saw robust demand for Proteograph ONE, increasing instrument shipments

Outlook

* Seer expects full-year 2025 revenue between $17 mln and $18 mln

Result Drivers

* PROTEOGRAPH DEMAND - Robust demand for Proteograph ONE workflow drove increased instrument shipments

* PUBLICATION RECORD - Record number of third-party publications validating Proteograph technology

* PRODUCT SALES - Higher product sales contributed to revenue growth

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q3 $4.12

Revenue mln

Q3 EPS -$0.32

Q3 Net -$18.23

Income mln

Q3 Gross 51.00%

Margin

Q3 Gross $2.11

Profit mln

Q3 $21.46

Operatin mln

g

Expenses

Analyst Coverage

* The one available analyst rating on the shares is "buy"

* The average consensus recommendation for the office equipment peer group is "buy"

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)